U.S. flag

An official website of the United States government

NM_000218.3(KCNQ1):c.783G>C (p.Glu261Asp) AND Long QT syndrome

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Nov 17, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001381194.8

Allele description [Variation Report for NM_000218.3(KCNQ1):c.783G>C (p.Glu261Asp)]

NM_000218.3(KCNQ1):c.783G>C (p.Glu261Asp)

Gene:
KCNQ1:potassium voltage-gated channel subfamily Q member 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11p15.5
Genomic location:
Preferred name:
NM_000218.3(KCNQ1):c.783G>C (p.Glu261Asp)
HGVS:
  • NC_000011.10:g.2572848G>C
  • NG_008935.1:g.132858G>C
  • NM_000218.3:c.783G>CMANE SELECT
  • NM_001406836.1:c.783G>C
  • NM_001406837.1:c.513G>C
  • NM_181798.2:c.402G>C
  • NP_000209.2:p.Glu261Asp
  • NP_000209.2:p.Glu261Asp
  • NP_001393765.1:p.Glu261Asp
  • NP_001393766.1:p.Glu171Asp
  • NP_861463.1:p.Glu134Asp
  • NP_861463.1:p.Glu134Asp
  • LRG_287t1:c.783G>C
  • LRG_287t2:c.402G>C
  • LRG_287:g.132858G>C
  • LRG_287p1:p.Glu261Asp
  • LRG_287p2:p.Glu134Asp
  • NC_000011.9:g.2594078G>C
  • NM_000218.2:c.783G>C
  • NM_181798.1:c.402G>C
  • NR_040711.2:n.676G>C
  • P51787:p.Glu261Asp
Protein change:
E134D
Links:
UniProtKB: P51787#VAR_008944; dbSNP: rs199472721
NCBI 1000 Genomes Browser:
rs199472721
Molecular consequence:
  • NM_000218.3:c.783G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406836.1:c.783G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406837.1:c.513G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_181798.2:c.402G>C - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Name:
Long QT syndrome (LQTS)
Identifiers:
MONDO: MONDO:0002442; MeSH: D008133; MedGen: C0023976

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001579495Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Jul 24, 2023)
germlineclinical testing

PubMed (8)
[See all records that cite these PMIDs]

SCV004843088All of Us Research Program, National Institutes of Health
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Nov 17, 2023)
germlineclinical testing

PubMed (13)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknown1not providednot provided108544not providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

KVLQT1 C-terminal missense mutation causes a forme fruste long-QT syndrome.

Donger C, Denjoy I, Berthet M, Neyroud N, Cruaud C, Bennaceur M, Chivoret G, Schwartz K, Coumel P, Guicheney P.

Circulation. 1997 Nov 4;96(9):2778-81.

PubMed [citation]
PMID:
9386136
See all PubMed Citations (14)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001579495.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (8)

Description

For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects KCNQ1 function (PMID: 11530100, 15935335). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 53104). This missense change has been observed in individual(s) with Jervell and Lange-Nielsen syndrome and clinically confirmed long QT syndrome (PMID: 10704188, 11530100, 15840476, 18752142, 23631430, 26675252; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glutamic acid, which is acidic and polar, with aspartic acid, which is acidic and polar, at codon 261 of the KCNQ1 protein (p.Glu261Asp).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From All of Us Research Program, National Institutes of Health, SCV004843088.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (13)

Description

The c.783G>C (p.Glu261Asp) variant in KCNQ1 gene, that encodes for potassium voltage-gated channel subfamily Q member 1, has been identified in heterozygous status in multiple unrelated individuals (at least 9) with Long QT syndrome (LQTS) (PMID: 15840476, 18752142, 23631430, 26675252) and in one individual affected with Jervell and Lange-Nielsen syndrome (PMID:11140949). This variant has also been observed in compound heterozygous status (with another pathogenic variant p.Glu530*) in two individuals with Jervell and Lange-Nielsen syndrome (JLNS) (PMID: 10704188, 26675252). Expermental studies using Xenopus oocytes showed strong dominant negative effect resulted in pronounced reduction in current amplitude compared to control (PMID: 11530100). When co-expressed with KCNE1 in CHO-K1 and murine myocyte cell line, this variant showed retention of protein to the endoplasmic reticulum and decrease in tail current density (PMID: 15935335). In-silico computational prediction tools suggest that the p.Glu261Aspvariant may have deleterious effect on the protein function (REVEL score: 0.867). This variant is found to be absent in the general population database, gnomAD and interpreted as pathogenic by a submitter in the ClinVar database (ClinVar ID: 53104). Other missense variants substituting the same amino acid (p.Glu261Leu, p.Glu261Gln, p.Glu261Lys) are reported in multiple individuals with LQTS (PMID: 9386136, 19716085, 26669661, 27041096) and classified as likely pathogenic/pathogenic by several submitters in the ClinVar (ClinVar ID: 405253, 67106, 53103). Therefore, the c.783G>C (p.Glu261Asp) variant in the KCNQ1 gene is classified as pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknown108544not providednot provided1not providednot providednot provided

Last Updated: Sep 29, 2024